Hua Fengmao

This profile gathers the share dealings of Hua Fengmao in Viva Biotech Holdings. We count 10 filings; the first trade dates from 9 May 2019 and the latest from 30 June 2021.

The open-market side counts 4 purchases for €1.7M alongside 1 sale for €27.5M. No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2021, the count stands at no purchases and 1 sale.

In size, the median ticket on the buying side is €771k. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. After 3 purchases with a full 90-day history, the hit rate stands at 33% and the median 90-day move at -2.1%. They describe history only and say nothing certain about the share price ahead.

The record was last updated on 5 July 2021 with a transaction in Viva Biotech Holdings. The last insider purchase was made public on 16 December 2020, 2,138 days ago. Typically, a trade is published a median of 4 days after it takes place. Until a filing is published, the market cannot know about the trade. Source: insider filings from HKEX. Past trades are no guide to future returns.